Cor Vasa 2012, 54(11-12):e369-e374 | DOI: 10.1016/j.crvasa.2012.11.007

Catheter ablation for atrial fibrillation - Single center experience

Luděk Haman*, Hana Dostálová, Petr Pařízek
I. interní kardioangiologická klinika, Lékařská fakulta Univerzity Karlovy v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika

Aims: Catheter ablation (CA) has become standard therapy for atrial fibrillation, especially for paroxysmal atrial fibrillation. Precise single center follow-up (FU) data (especially long-term FU data) are published infrequently.

Methods: We studied 303 consecutive patients (172 males, 131 females, mean age 57 years) who underwent catheter ablation for atrial fibrillation (489 procedures) in years 2004-2012. Clinical examination, ECG, 24-h or 7-day Holter monitoring and quality-of-life (QoL) measurement (EQ-5D) was performed at 3-, 6-, 12-, 18- and 24-month FU.

Results: FU data longer than 6 months after the first procedure are available for 135 patients with paro-xysmal, 84 patients with persistent and 48 patients with long-standing persistent AF. The success rate after 6 months after the first procedure (sinus rhythm without AA drugs, no arrhythmias) was 48% for paroxysmal, 43% for persistent and 44% for long-standing persistent AF. The complication rate was 3.3% (16 patients, no deaths, no pulmonary vein stenosis, 5 incidents of pericardial effusion treated with pericardiocentesis; 1 transitory ischemic attack; the remainder were local complications in the groin). The success rate after the last procedure (mean FU 24 ± 16 months, 1.6 procedure per patient) was 80% for paroxysmal and 58% for persistent and long-standing persistent AF. QoL increased significantly in all groups of patients.

Conclusion: With the standard procedure we can achieve acceptable results (success rate 60-80% with repeated procedures) with low complication rate even in a "lower volume" center. In selected patients (with paroxysmal AF preferring interventional treatment) CA can be recommended as first-line therapy for rhythm control. CA improves QoL in our patients with AF. As there is no gold standard to measure QoL in AF pa-tients, EQ-5D seems to be a simple, quick and useful tool.

Keywords: Atrial fibrillation; Catheter ablation; Quality of life

Received: October 17, 2012; Revised: November 10, 2012; Accepted: November 12, 2012; Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haman L, Dostálová H, Pařízek P. Catheter ablation for atrial fibrillation - Single center experience. Cor Vasa. 2012;54(11-12):e369-374. doi: 10.1016/j.crvasa.2012.11.007.
Download citation

References

  1. C. Pappone, V. Santinelli, Atrial fibrillation: state of the art, The American Journal of Cardiology 96 (2005) 59L-64L. Go to original source... Go to PubMed...
  2. M.D. O'Neill, M. Wright, S. Knecht, et al., Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint, European Heart Journal 30 (2009) 1105-1112. Go to original source... Go to PubMed...
  3. M. Fiala, J. Chovancík, D. Wojnarová, et al., Results of complex left atrial ablation of long-lasting persistent atrial fibrillation, Journal of Interventional Cardiac Electrophysiology 23 (2008) 189-198. Go to original source... Go to PubMed...
  4. W. Greiner, T. Weijnen, M. Nieuwenhuizen, et al., A single European currency for EQ-5D health states. Results from a six country study, The European Journal of Health Economics 4 (2003) 222-231. Go to original source... Go to PubMed...
  5. H. Mlcochova, J. Tintera, V. Porod, et al., Magnetic resonance angiography of pulmonary veins: implications for catheter ablation of atrial fibrillation, Pacing and Clinical Electrophysiology 28 (2005) 1073-1080. Go to original source... Go to PubMed...
  6. C. Bonanno, M. Paccanaro, L. La Vecchia, et al., Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials, The Journal of Cardiovascular Medicine 11 (2010) 408-418. Go to original source... Go to PubMed...
  7. R. Cappato, H. Calkins, S.A. Chen, et al., Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation. Arrhythmia and Electrophysiology 3 (2010) 32-38. Go to original source... Go to PubMed...
  8. O.M. Wazni, N.F. Marrouche, D.O. Martin, et al., Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. A randomized trial, The Journal of the American Medical Association 293 (2005) 2634-2640. Go to original source... Go to PubMed...
  9. P. Jais, B. Cauchemez, L. Macle, et al., Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation 118 (2008) 2498-2505. Go to original source... Go to PubMed...
  10. D.J. Wilber, C. Pappone, P. Neuzil, et al., Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial, The Journal of the American Medical Association 303 (2010) 333-340. Go to original source... Go to PubMed...
  11. C. Quercioli, G. Mesina, E. Barbini, et al., Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performance of three tools, The European Journal of Health Economics 10 (2009) 389-397. Go to original source... Go to PubMed...
  12. A.J. Camm, G.Y.H. Lip, R. De Caterina, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation, European Heart Journal 33 (2012) 2719-2747. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.